Ceros Capital Markets, the investment banking division of Ceros Financial Services, has completed a USD15 million Series D (Series A4) financing round for Pristine Surgical.
Pristine Surgical will apply the funding toward commercialisation of its single-use visualisation platform developed for surgical and diagnostic endoscopic procedures.
Ceros focuses on fundraising for early-stage medical technology and medical device companies that are developing disruptive technologies, particularly for diagnostic and non-invasive procedures. The firm is targeting to raise USD150 million this year. Ceros completed USD117 million in transactions in the medtech sector in 2021 and USD145 million since 2020.
